TCL Archive The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power October 31, 2014
TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996
TCL Archive In Brief: Two Major Appointments Made At Fox Chase; HHS Names Task Force to Look At DRG Research Impact April 20, 1984
